Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen
2010 ◽
Vol 16
(2)
◽
pp. S233-S234
2011 ◽
Vol 5
(6)
◽
pp. 543-549
◽
2009 ◽
Vol 15
(2)
◽
pp. 72-73
2019 ◽
Vol 90
(3)
◽
pp. 157-164
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 6660-6660